Literature DB >> 29606482

Planning management and delivery of the growth-restricted fetus.

Ahmet A Baschat1.   

Abstract

A uniform approach to management of fetal growth restriction (FGR) improves outcome, prevents stillbirth, and allows appropriately timed delivery. An estimated fetal weight below the tenth percentile with coexisting abnormal umbilical artery (UA), middle cerebral artery (MCA), or cerebroplacental ratio Doppler index best identifies the small fetus requiring surveillance. Placental perfusion defects are more common earlier in gestation; accordingly, early-onset (≤32 weeks of gestation) and late-onset (>32 weeks) FGR differ in clinical phenotype. In early-onset FGR, progression of UA Doppler abnormality determines clinical acceleration, while abnormal ductus venosus (DV) Doppler precedes deterioration of biophysical variables and stillbirth. Accordingly, late DV Doppler changes, abnormal biophysical variables, or an abnormal cCTG require delivery. In late-onset FGR, MCA Doppler abnormalities precede deterioration and stillbirth. However, from 34 to 38 weeks, randomized evidence on optimal delivery timing is lacking. From 38 weeks onward, the balance of neonatal versus fetal risks favors delivery.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Biophysical profile; Delivery timing; Diagnosis; Doppler ultrasound; Fetal growth restriction; Surveillance

Mesh:

Year:  2018        PMID: 29606482     DOI: 10.1016/j.bpobgyn.2018.02.009

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  13 in total

1.  Exploring in vivo placental microstructure in healthy and growth-restricted pregnancies through diffusion-weighted magnetic resonance imaging.

Authors:  Nickie Andescavage; Wonsang You; Marni Jacobs; Kushal Kapse; Jessica Quistorff; Dorothy Bulas; Homa Ahmadzia; Alexis Gimovsky; Ahmet Baschat; Catherine Limperopoulos
Journal:  Placenta       Date:  2020-03-06       Impact factor: 3.481

2.  Cell-Free DNA (cfDNA) Fetal Fraction in Early- and Late-Onset Fetal Growth Restriction.

Authors:  Danila Morano; Stefania Rossi; Cristina Lapucci; Maria Carla Pittalis; Antonio Farina
Journal:  Mol Diagn Ther       Date:  2018-10       Impact factor: 4.074

Review 3.  The Role of Kisspeptin in the Pathogenesis of Pregnancy Complications: A Narrative Review.

Authors:  Magdalena Szydełko-Gorzkowicz; Elżbieta Poniedziałek-Czajkowska; Radzisław Mierzyński; Maciej Sotowski; Bożena Leszczyńska-Gorzelak
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

4.  Circulating mRNAs are differentially expressed in pregnancies with severe placental insufficiency and at high risk of stillbirth.

Authors:  Natalie J Hannan; Owen Stock; Rebecca Spencer; Clare Whitehead; Anna L David; Katie Groom; Scott Petersen; Amanda Henry; Joanne M Said; Sean Seeho; Stefan C Kane; Lavinia Gordon; Sally Beard; Kantaraja Chindera; Smita Karegodar; Richard Hiscock; Natasha Pritchard; Tu'uhevaha J Kaitu'u-Lino; Susan P Walker; Stephen Tong
Journal:  BMC Med       Date:  2020-05-22       Impact factor: 8.775

5.  Tadalafil Treatment Ameliorates Hypoxia and Alters Placental Expression of Proteins Downstream of mTOR Signaling in Fetal Growth Restriction.

Authors:  Kyoka Tsuchiya; Kayo Tanaka; Hiroaki Tanaka; Shintaro Maki; Naosuke Enomoto; Sho Takakura; Masafumi Nii; Kuniaki Toriyabe; Shinji Katsuragi; Tomoaki Ikeda
Journal:  Medicina (Kaunas)       Date:  2020-12-21       Impact factor: 2.430

Review 6.  Comparison of treatments for the prevention of fetal growth restriction in obstetric antiphospholipid syndrome: a systematic review and network meta-analysis.

Authors:  Maria Letizia Urban; Alessandra Bettiol; Irene Mattioli; Alfredo Vannacci; Elena Silvestri; Domenico Prisco; Giacomo Emmi; Gerardo Di Scala; Laura Avagliano; Niccolò Lombardi; Giada Crescioli; Gianni Virgili; Caterina Serena; Federico Mecacci; Claudia Ravaldi
Journal:  Intern Emerg Med       Date:  2021-01-21       Impact factor: 3.397

7.  Acute SARS-CoV-2 alpha variant infection leading to placental insufficiency and fetal distress.

Authors:  Sander Dumont; Jonas Balduyck; Marijke Reynders; Lieve Vanwalleghem; Barbara Lebbe
Journal:  J Med Virol       Date:  2021-10-12       Impact factor: 20.693

8.  An integrated approach based on advanced CTG parameters and Doppler measurements for late growth restriction management.

Authors:  Giovanni Magenes; Giuseppe Maria Maruotti; Maria Gabriella Signorini; Giuseppina Esposito; Nicolò Pini; Salvatore Tagliaferri; Marta Campanile; Fulvio Zullo
Journal:  BMC Pregnancy Childbirth       Date:  2021-11-16       Impact factor: 3.007

9.  Third-trimester Reference Ranges for Cerebroplacental Ratio and Pulsatility Index for Middle Cerebral Artery and Umbilical Artery in Normal-growth Singleton Fetuses in the Israeli Population.

Authors:  Efraim Zohav; Eyal Zohav; Mark Rabinovich; Ahmad Alasbah; Simon Shenhav; Hadar Sofer; Yaniv S Ovadia; Eyal Y Anteby; Leonti Grin
Journal:  Rambam Maimonides Med J       Date:  2019-10-29

10.  NF-κB regulation in maternal immunity during normal and IUGR pregnancies.

Authors:  Gaayathri Ariyakumar; Jonathan M Morris; Kelly J McKelvey; Anthony W Ashton; Sharon A McCracken
Journal:  Sci Rep       Date:  2021-10-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.